Synthesis, Antioxidant and In-Silico Studies of Potent Urease Inhibitors: N-(4{[(4-Methoxyphenethyl)-(substituted)amino]sulfonyl}phenyl)acetamides

被引:6
|
作者
Abbasi, Muhammad Athar [1 ,2 ]
Raza, Hussain [1 ]
Rehman, Aziz ur [2 ]
Siddiqui, Sahahat Zahra [2 ]
Nazir, Majid [2 ]
Mumtaz, Ayesha [2 ]
Shah, Syed Adnan Ali [3 ,4 ]
Seo, Sung-Yum [1 ]
Hassan, Mubashir [1 ]
机构
[1] Kongju Natl Univ, Dept Biol Sci, Coll Nat Sci, Gongju Si 32588, South Korea
[2] Govt Coll Univ, Dept Chem, Lahore, Pakistan
[3] Univ Teknol MARA, Fac Pharmacyn, Puncak Alam Campus, Selangor Darul Ehsan, Malaysia
[4] Univ Teknol MARA, Atta Ur Rahman Inst Nat Prod Discovery AuRIns, Puncak Alam Campus, Selangor Darul Ehsan, Malaysia
基金
新加坡国家研究基金会;
关键词
Sulfonamides; acetamides; alkyl/aralkyl halides; spectral analysis; antioxidant; Urease inhibition; Molecular docking; HELICOBACTER-PYLORI; SULFONAMIDES; DERIVATIVES; DOCKING; VITRO;
D O I
10.1055/a-0654-5074
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, a new series of sulfonamides derivatives was synthesized and their inhibitory effects on DPPH and jack bean urease were evaluated. The in silico studies were also applied to ascertain the interactions of these molecules with active site of the enzyme. Synthesis was initiated by the nucleophilic substitution reaction of 2-(4-methoxyphenyl)-1-ethanamine (1) with 4-(acetylamino)benzenesulfonyl chloride (2) in aqueous sodium carbonate at pH 9. Precipitates collected were washed and dried to obtain the parent molecule, N(4{[(4methoxy-phenethyl)amino]sulfonyl} phenyl)acetamide (3). Then, this parent was reacted with different alkyl/aralkyl halides, (4a-m), using dimethylformamide (DMF) as solvent and LiH as an activator to produce a series of new N-(4-{[(4-methoxyphenethyl)-(substituted)amino]sulfonyllphenyl)acetamides (5a-m). All the synthesized compounds were characterized by IR, EI-MS, H-1-NMR, C-13-NMR and CHN analysis data. All of the synthesized compounds showed higher urease inhibitory activity than the standard thiourea. The compound 5f exhibited very excellent enzyme inhibitory activity with IC50 value of 0.0171 +/- 0.0070 mu M relative to standard thiourea having IC50 value of 4.7455 +/- 0.0546 mu M. Molecular docking studies suggested that ligands have good binding energy values and bind within the active region of taget protein. Chemo-informatics properties were evaluated by computational approaches and it was found that synthesized compounds mostly obeyed the Lipinski' rule.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 50 条
  • [1] Synthesis, enzyme inhibitory kinetics mechanism and computational study of N-(4-methoxyphenethyl)-N-(substituted)-4-methylbenzenesulfonamides as novel therapeutic agents for Alzheimer's disease
    Abbasi, Muhammad Athar
    Hassan, Mubashir
    Aziz-ur-Rehman
    Siddiqui, Sabahat Zahra
    Shah, Syed Adnan Ali
    Raza, Hussain
    Seo, Sung Yum
    PEERJ, 2018, 6
  • [2] Synthesis, In Vitro, and In Silico Studies of N-(Substituted-Phenyl)-3-(4-Phenyl-1-Piperazinyl)propanamides as Potent Alkaline Phosphatase Inhibitors
    Abbasi, M. A.
    Nazir, M.
    Aziz-ur-Rehman
    Siddiqui, S. Z.
    Raza, Hussain
    Zafar, Ayesha
    Shah, S. A. A.
    Shahid, M.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2021, 47 (05) : 1086 - 1096
  • [3] Synthesis of new 2-{2,3-dihydro-1,4-benzodioxin-6-yl[(4-methylphenyl) sulfonyl]amino}-N-(un/substituted-phenyl) acetamides as α-glucosidase and acetylcholinesterase inhibitors and their in silico study
    Abbasi, Muhammad Athar
    Riaz, Sajid
    Aziz-ur-Rehman
    Siddiqui, Sabahat Zahra
    Shah, Syed Adnan Ali
    Ashraf, Muhammad
    Lodhi, Muhammad Arif
    Khan, Farman Ali
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 55
  • [4] Synthesis, In Vitro, and In Silico Studies of N-(Substituted-Phenyl)-3-(4-Phenyl-1-Piperazinyl)propanamides as Potent Alkaline Phosphatase Inhibitors
    M. A. Abbasi
    M. Nazir
    S. Z. Aziz-ur-Rehman
    Hussain Siddiqui
    Ayesha Raza
    S. A. A. Zafar
    M. Shah
    Russian Journal of Bioorganic Chemistry, 2021, 47 : 1086 - 1096
  • [5] Synthesis, computational studies and in-silico antimicrobial evaluation of novel N-(substituted) sulfonyl carboxamide bearing pyrrolidine-2,5-dione
    Bougheloum, Chafika
    Bouskia, Soumaya
    SYNTHETIC COMMUNICATIONS, 2025, : 496 - 520
  • [6] Design, synthesis and computational studies of N-(substituted-phenyl)-4-(4-phenyl-1-piperazinyl)butanamides as potent anti-melanogenic and tyrosinase inhibitors
    Raza, Hussain
    Abbasi, Muhammad Athar
    Aziz-ur-Rehman
    Siddiqui, Sabahat Zahra
    Hassan, Mubashir
    Shah, Syed Adnan Ali
    Shahid, Muhammad
    Hong, Hansol
    Seo, Sung-Yum
    JOURNAL OF MOLECULAR STRUCTURE, 2020, 1210 (1210)
  • [7] Therapeutic potential of N4-substituted thiosemicarbazones as new urease inhibitors: Biochemical and in silico approach
    Islam, Muhammad
    Khan, Ajmal
    Shehzad, Muhammad Tariq
    Khiat, Mohammed
    Halim, Sobia Ahsan
    Hameed, Abdul
    Shah, Syed Raza
    Basri, Rabia
    Anwar, Muhammad U.
    Hussain, Javid
    Csuk, Rene
    Al-Harrasi, Ahmed
    Shafiq, Zahid
    BIOORGANIC CHEMISTRY, 2021, 109
  • [8] Design, synthesis, in vitro, and in silico studies of 4-fluorocinnamaldehyde based thiosemicarbazones as urease inhibitors
    Islam, Muhammad
    Ullah, Saeed
    Khan, Ajmal
    Batool, Zahra
    Mali, Suraj N.
    Gurav, Shailesh S.
    Dahlous, Kholood A.
    Mohammad, Saikh
    Hussain, Javid
    Al-Harrasi, Ahmed
    Shafiq, Zahid
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [9] Novel N,N-dimethylbarbituric-pyridinium derivatives as potent urease inhibitors: Synthesis, in vitro, and in silico studies
    Biglar, Mahmood
    Mirzazadeh, Roghieh
    Asadi, Mehdi
    Sepehri, Saghi
    Valizadeh, Yousef
    Sarrafi, Yaghoub
    Amanlou, Massoud
    Larijani, Bagher
    Mohammadi-Khanaposhtani, Maryam
    Mahdavi, Mohammad
    BIOORGANIC CHEMISTRY, 2020, 95
  • [10] Synthesis, In Silico Studies, and Antioxidant and Tyrosinase Inhibitory Potential of 2-(Substituted Phenyl) Thiazolidine-4-Carboxamide Derivatives
    Zargaham, Muhammad Kazim
    Ahmed, Madiha
    Akhtar, Nosheen
    Ashraf, Zaman
    Abdel-Maksoud, Mostafa A.
    Aufy, Mohammed
    Nadeem, Humaira
    PHARMACEUTICALS, 2023, 16 (06)